Results
|
|
1041.
|
A Phase I/II study of the combination of lapatinib and oral vinorelbine in HER2-positive metastatic breast cancer. [electronic resource] by
- Chen, Tom Wei-Wu
- Yeh, Dah-Cherng
- Chao, Tsu-Yi
- Lin, Ching-Hung
- Chow, Louis Wing-Cheong
- Chang, Dwan-Ying
- Hsieh, Yao-Yu
- Huang, Shu-Min
- Cheng, Ann-Lii
- Lu, Yen-Shen
- Consortium, Taiwan Breast Cancer
Producer: 20180507
In:
Japanese journal of clinical oncology vol. 48
Availability: No items available.
|
|
|
1042.
|
|
|
|
1043.
|
|
|
|
1044.
|
|
|
|
1045.
|
|
|
|
1046.
|
Survival outcomes of the NeoALTTO study (BIG 1-06): updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast cancer. [electronic resource] by
- Huober, Jens
- Holmes, Eileen
- Baselga, José
- de Azambuja, Evandro
- Untch, Michael
- Fumagalli, Debora
- Sarp, Severine
- Lang, Istvan
- Smith, Ian
- Boyle, Frances
- Xu, Binghe
- Lecocq, Christophe
- Wildiers, Hans
- Jouannaud, Christelle
- Hackman, John
- Dasappa, Lokanatha
- Ciruelos, Eva
- Toral Pena, Juan Carlos
- Adamchuk, Hryhoriy
- Hickish, Tamas
- de la Pena, Lorena
- Jackisch, Christian
- Gelber, Richard D
- Piccart-Gebhart, Martine
- Di Cosimo, Serena
Producer: 20200608
In:
European journal of cancer (Oxford, England : 1990) vol. 118
Availability: No items available.
|
|
|
1047.
|
Phase I study of lapatinib plus trametinib in patients with KRAS-mutant colorectal, non-small cell lung, and pancreatic cancer. [electronic resource] by
- Huijberts, Sanne C F A
- van Geel, Robin M J M
- van Brummelen, Emilie M J
- Opdam, Frans L
- Marchetti, Serena
- Steeghs, Neeltje
- Pulleman, Saskia
- Thijssen, Bas
- Rosing, Hilde
- Monkhorst, Kim
- Huitema, Alwin D R
- Beijnen, Jos H
- Bernards, René
- Schellens, Jan H M
Producer: 20201117
In:
Cancer chemotherapy and pharmacology vol. 85
Availability: No items available.
|
|
|
1048.
|
|
|
|
1049.
|
|
|
|
1050.
|
|
|
|
1051.
|
Phase I study of continuous and intermittent schedules of lapatinib in combination with vinorelbine in solid tumors. [electronic resource] by
- Chew, H K
- Somlo, G
- Mack, P C
- Gitlitz, B
- Gandour-Edwards, R
- Christensen, S
- Linden, H
- Solis, L J
- Yang, X
- Davies, A M
Producer: 20120713
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 23
Availability: No items available.
|
|
|
1052.
|
Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: a randomised, controlled, phase 3 trial. [electronic resource] by
- Goss, Paul E
- Smith, Ian E
- O'Shaughnessy, Joyce
- Ejlertsen, Bent
- Kaufmann, Manfred
- Boyle, Frances
- Buzdar, Aman U
- Fumoleau, Pierre
- Gradishar, William
- Martin, Miguel
- Moy, Beverly
- Piccart-Gebhart, Martine
- Pritchard, Kathleen I
- Lindquist, Deborah
- Chavarri-Guerra, Yanin
- Aktan, Gursel
- Rappold, Erica
- Williams, Lisa S
- Finkelstein, Dianne M
Producer: 20130403
In:
The Lancet. Oncology vol. 14
Availability: No items available.
|
|
|
1053.
|
Correlation of HER2, p95HER2 and HER3 expression and treatment outcome of lapatinib plus capecitabine in her2-positive metastatic breast cancer. [electronic resource] by
- Han, Sae-Won
- Cha, Yongjun
- Paquet, Agnes
- Huang, Weidong
- Weidler, Jodi
- Lie, Yolanda
- Sherwood, Thomas
- Bates, Michael
- Haddad, Mojgan
- Park, In Hae
- Oh, Do-Youn
- Lee, Keun Seok
- Im, Seock-Ah
- Bang, Yung-Jue
- Ro, Jungsil
- Kim, Tae-You
Producer: 20130402
In:
PloS one vol. 7
Availability: No items available.
|
|
|
1054.
|
|
|
|
1055.
|
[Towards an integrated approach to cardiovascular toxicities related to the treatments of breast cancer]. [electronic resource] by
- Tanz, Rachid
- Magne, Nicolas
- Annede, Pierre
- Mery, Benoite
- Jacob, Julian
- Bauduceau, Olivier
- Trone, Jane-Chloé
- Guichard, Jean-Baptiste
- Meillan, Nicolas
- Kirova, Youlia
- Vedrine, Lionel
- Chargari, Cyrus
Producer: 20140925
In:
Bulletin du cancer vol. 101
Availability: No items available.
|
|
|
1056.
|
|
|
|
1057.
|
Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulation of the activity of the HER2-PI3K/AKT-FASN axis in vitro. [electronic resource] by
- Long, Xin-Hua
- Zhang, Guo-Mei
- Peng, Ai-Fen
- Luo, Qing-Feng
- Zhang, Lin
- Wen, Hui-Cai
- Zhou, Rong-Ping
- Gao, Song
- Zhou, Yang
- Liu, Zhi-Li
Producer: 20140905
In:
Oncology reports vol. 31
Availability: No items available.
|
|
|
1058.
|
Predictive Factors of Lapatinib and Capecitabine Activity in Patients with HER2-Positive, Trastuzumab-Resistant Metastatic Breast Cancer: Results from the Italian Retrospective Multicenter HERLAPAC Study. [electronic resource] by
- Gori, Stefania
- Inno, Alessandro
- Rossi, Valentina
- Turazza, Monica
- Fiorio, Elena
- Fabi, Alessandra
- Bisagni, Giancarlo
- Foglietta, Jennifer
- Santini, Daniele
- Pavese, Ida
- Pellegrino, Arianna
- Zambelli, Alberto
- Vici, Patrizia
- Leonardi, Vita
- Barni, Sandro
- Saracchini, Silvana
- Bogina, Giuseppe
- Marchetti, Fabiana
- Duranti, Simona
- Lunardi, Gianluigi
- Montemurro, Filippo
Producer: 20170710
In:
PloS one vol. 11
Availability: No items available.
|
|
|
1059.
|
Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies. [electronic resource] by
- Toomey, Sinead
- Eustace, Alexander J
- Fay, Joanna
- Sheehan, Katherine M
- Carr, Aoife
- Milewska, Malgorzata
- Madden, Stephen F
- Teiserskiene, Ausra
- Kay, Elaine W
- O'Donovan, Norma
- Gallagher, William
- Grogan, Liam
- Breathnach, Oscar
- Walshe, Janice
- Kelly, Catherine
- Moulton, Brian
- Kennedy, M John
- Gullo, Guiseppe
- Hill, Arnold D
- Power, Colm
- Duke, Deirdre
- Hambly, Niamh
- Crown, John
- Hennessy, Bryan T
Producer: 20180427
In:
Breast cancer research : BCR vol. 19
Availability: No items available.
|
|
|
1060.
|
|